Richard Jones's Colleagues at QED Therapeutics
Richard Jones's Contact Details
HQ
650-231-4088
650-231-4088
Location
Brisbane,California,United States
Brisbane,California,United States
Company
QED Therapeutics
QED Therapeutics
Richard Jones's Company Details
QED Therapeutics, a subsidiary of BridgeBio Pharma, is a biotechnology company focused on precision medicine for FGFR-driven disorders. Our lead candidate is infigratinib, a best-in-class FGFR kinase inhibitor that has shown meaningful clinical activity in chemotherapy-refractory cholangiocarcinoma with FGFR2 fusions. QED is also evaluating infigratinib in preclinical studies for the treatment of achondroplasia. We plan to develop infigratinib in additional FGFR-driven tumor types and rare disorders.
Frequently Asked Questions about Richard Jones
Richard Jones currently works for QED Therapeutics.
Richard Jones's role at QED Therapeutics is Associate Director of Quality Assurance.
Richard Jones's email address is ***@qedtx.com. To view Richard Jones's full email address, please signup to ConnectPlex.
Richard Jones works in the Research industry.
Richard Jones's colleagues at QED Therapeutics are Cortney Galasso, Kim Ho, Vanessa Solis, Morgan Paull, Jacki Fontaine, Angela Monterrubio, Micaela Rodine and others.
Richard Jones's phone number is 650-231-4088